Invictus Oncology Pvt. Ltd has raised Rs.10.5 crore from investors Navam Capital and Aarin Capital in its first round of fund-raising. The company develops chemotherapy models and will deploy the new financing to advance the development of platinum chemotherapies used in the treatment of several types of cancer, including lung, testicular, colorectal, and childhood cancers. Invictus was co-founded by Shiladitya Sengupta, assistant professor of medicine at Harvard Medical School.
Aarin Capital, led by Ranjan Pai, MD and CEO, Manipal Education and T.V. Mohandas Pai, former director at Infosys, invests in companies offering innovative healthcare, life sciences and technology-based products or services. Navam Capital focuses on seed and early-stage investments in energy, technology and healthcare.
Venture Intelligence is the leading provider of data and analysis on Private Company Financials, Transactions (private equity, venture capital and M&A) & their Valuations in India. Click Here to view our products list including the Free Deal Digest Weekly: India's First & Most Exhaustive Transactions Newsletter.